Eudaimonia Partners LLC cut its position in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 59.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,969 shares of the company’s stock after selling 8,839 shares during the period. Eudaimonia […] Read this story